Paper
External validation of the NADIR model for early prostate‐specific antigen response prediction in enzalutamide‐treated metastatic hormone‐sensitive prostate cancer: An analysis of the ARCHES trial
Cancer · 2026 · Soumyajit Roy, Andrew J Armstrong, Neeraj Agarwal et al.
